1. Home
  2. AXSM vs BFAM Comparison

AXSM vs BFAM Comparison

Compare AXSM & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • BFAM
  • Stock Information
  • Founded
  • AXSM 2012
  • BFAM 1986
  • Country
  • AXSM United States
  • BFAM United States
  • Employees
  • AXSM N/A
  • BFAM N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • BFAM Other Consumer Services
  • Sector
  • AXSM Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • AXSM Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • AXSM 5.9B
  • BFAM 5.7B
  • IPO Year
  • AXSM 2015
  • BFAM 1997
  • Fundamental
  • Price
  • AXSM $145.72
  • BFAM $96.55
  • Analyst Decision
  • AXSM Strong Buy
  • BFAM Buy
  • Analyst Count
  • AXSM 20
  • BFAM 7
  • Target Price
  • AXSM $176.00
  • BFAM $132.43
  • AVG Volume (30 Days)
  • AXSM 547.8K
  • BFAM 934.6K
  • Earning Date
  • AXSM 11-03-2025
  • BFAM 10-30-2025
  • Dividend Yield
  • AXSM N/A
  • BFAM N/A
  • EPS Growth
  • AXSM N/A
  • BFAM 72.95
  • EPS
  • AXSM N/A
  • BFAM 3.47
  • Revenue
  • AXSM $561,263,000.00
  • BFAM $2,874,055,000.00
  • Revenue This Year
  • AXSM $63.66
  • BFAM $11.17
  • Revenue Next Year
  • AXSM $54.46
  • BFAM $6.93
  • P/E Ratio
  • AXSM N/A
  • BFAM $28.71
  • Revenue Growth
  • AXSM 65.83
  • BFAM 9.38
  • 52 Week Low
  • AXSM $75.56
  • BFAM $91.49
  • 52 Week High
  • AXSM $146.53
  • BFAM $132.99
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 72.66
  • BFAM 41.75
  • Support Level
  • AXSM $136.00
  • BFAM $95.87
  • Resistance Level
  • AXSM $144.15
  • BFAM $101.94
  • Average True Range (ATR)
  • AXSM 5.82
  • BFAM 3.46
  • MACD
  • AXSM 0.32
  • BFAM 0.13
  • Stochastic Oscillator
  • AXSM 99.54
  • BFAM 28.42

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: